Impaired microbial synthesis of AhR ligands leads to the deterioration of mucosal barrier integrity and diminished secretion of GLP-1, with subsequent contributions to the onset of metabolic syndrome, type 2 diabetes mellitus (T2DM), high body mass index, and hypertension [74]. Here, AHR is linked to metabolic syndrome.